Gianazza Elisabetta, Miller Ingrid, Palazzolo Luca, Parravicini Chiara, Eberini Ivano
Dipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Via Balzaretti 9, I-20133 Milan, Italy.
Institut für Medizinische Biochemie, Veterinärmedizinische Universität Wien, Veterinärplatz 1, A-1210 Wien, Austria.
J Proteomics. 2016 May 17;140:62-80. doi: 10.1016/j.jprot.2016.04.002. Epub 2016 Apr 10.
The first sections of this review compile and discuss strategies and protocols for managing plasma/serum as a source of biomarkers relevant to human disease. In many such cases, depletion of abundant protein(s) is a crucial preliminary step to the procedure; specific conceptual and technical approaches, however, make it possible to effectively use to this purpose whole plasma/serum. The final sections focus instead on the complexity associated with each of the major serum/plasma proteins in terms of both, multiple molecular structures (existence of a number of protein species) and of multiple molecular functions (behavior as multifunctional/multitasking/moonlighting proteins). Reviewing evidence in these and some related fields (regulation of the synthetic pattern by proteins and non-protein compounds and its connection with health and disease) prompts the suggestion/recommendation that information on the abundant components of plasma/serum proteome is routinely obtained and processed/mined as a valuable contribution to the characterization of any non-physiological condition and to the understanding of its mechanisms and of its implications/sequels.
本综述的前几部分汇编并讨论了将血浆/血清作为与人类疾病相关的生物标志物来源进行管理的策略和方案。在许多此类情况下,去除丰富的蛋白质是该程序的关键初步步骤;然而,特定的概念和技术方法使得能够有效地将全血浆/血清用于此目的。最后几部分则聚焦于与每种主要血清/血浆蛋白相关的复杂性,这体现在多个分子结构(多种蛋白质种类的存在)和多种分子功能(作为多功能/多任务/兼职蛋白的行为)两方面。回顾这些及一些相关领域的证据(蛋白质和非蛋白质化合物对合成模式的调节及其与健康和疾病的关联)促使我们提出这样的建议:常规获取并处理/挖掘血浆/血清蛋白质组丰富成分的信息,以此作为对任何非生理状况特征描述以及对其机制、影响/后果理解的宝贵贡献。